Pharma BD Deal Intelligence
Novopharm, founded by the Dan family, became part of Teva in 2000 and was later renamed Teva Canada Limited, anchoring Teva's Canadian commercial operations.
Teva's 2000 acquisition of Canada-based Novopharm marked the start of a decade of generics consolidation that would later include Sicor, Ivax, and Barr.
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
Teva completed acquisition of Novopharm Limited in April 2000 for >$600M total consideration. Made Teva the largest generic drug company in North America with Novopharm's Canadian, US, and Hungarian operations.
Assessment window: 10yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd. / Novopharm Limited (this deal) | 2000 | $600M | 62 |
| Teva Pharmaceutical Industries Ltd. / Auspex Pharmaceuticals | 2015 | $3.5B | 86 |
| Teva Pharmaceutical Industries Ltd. / Biogal Pharmaceutical | 1995 | — | 82 |
| Teva Pharmaceutical Industries Ltd. / Sicor Inc. | 2003 | $3.4B | 68 |
| Teva Pharmaceutical Industries Ltd. / Ivax Corporation | 2006 | $7.4B | 63 |
| Teva Pharmaceutical Industries Ltd. / Ivax Corporation | 2005 | $7.4B | 62 |
| Teva Pharmaceutical Industries Ltd. / Barr Pharmaceuticals | 2008 | $7.5B | 58 |
← Browse all deals · How we score deals
More: 2000 deals · Teva Pharmaceutical Industries Ltd. deals · Multiple deals